Skip to main content
Techno Medica Co., Ltd. logo

Techno Medica Co., Ltd. — Investor Relations & Filings

Ticker · 6678 ISIN · JP3545110003 T Manufacturing
Open in API
Filings indexed 67 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country JP Japan
Listing T 6678

About Techno Medica Co., Ltd.

https://www.technomedica.co.jp/t01/Engl…

Techno Medica Co., Ltd. specializes in the research, development, manufacturing, and sale of in-vitro diagnostic (IVD) analyzers and automated pre-analytical systems for clinical laboratories. The company provides solutions that automate the workflow for blood and urine testing, covering processes from test registration and pre-analysis to patient identification and specimen transfer management. Its product portfolio includes next-generation IVD analyzers, such as electrolyte analyzers, and it is a leading manufacturer in the test tube market. The company focuses on delivering innovative products and services designed to enhance the efficiency, accuracy, and safety of laboratory diagnostics.

Recent filings

Filing Released Lang Actions
臨時報告書
Regulatory Filings Classification · 75% confidence The document is a Japanese ‘臨時報告書’ (extraordinary report) filed under the Financial Instruments and Exchange Act to notify investors and regulators of a change in the company’s external auditor. It does not contain financial statements itself (so not an Annual or Interim report), nor is it an actual audit report (so not AR). It is also not a proxy solicitation, dividend notice, or management presentation. It is a regulatory-compliance disclosure of an auditor change, which best fits the catch-all category for general compliance filings: Regulatory Filings (RNS).
2026-06-02 Japanese
会計監査人の異動に関するお知らせ
Regulatory Filings Classification · 20% confidence The document is a formal notice (“お知らせ”) by the company regarding the planned change of its external accounting auditor, resolved by the audit committee and board, to be proposed at the upcoming annual shareholders meeting. It does not contain the actual audit report, financial statements, nor is it a management change or earnings release. There is no dedicated category for auditor-change announcements, so it falls into the general regulatory announcement category.
2026-06-02 Japanese
株主優待制度の廃止に関するお知らせ
Regulatory Filings Classification · 8% confidence The document is a Japanese-language announcement by the company’s board regarding the abolition of its shareholder benefit program (“株主優待制度の廃止に関するお知らせ”). It does not contain financial statements or results, nor is it a notice of dividend, share issue, M&A, or management change. It is a standalone corporate announcement made via regulatory channels. There is no detailed financial report or proxy solicitation – it is a general corporate disclosure announcing a change in shareholder benefits. This fits the fallback category Regulatory Filings (RNS).
2026-06-02 Japanese
2026年3月期 決算説明会資料
Investor Presentation Classification · 92% confidence The document is a slide‐style presentation detailing Techno Medica’s business overview, full‐year FY2026 financial results, FY2027 outlook, and the 2026–28 mid‐term management plan. It includes numbered slides, tables, charts, and strategic narrative – characteristics of an Investor Presentation. It is not a statutory annual report (10‐K), nor a brief earnings release; it is a comprehensive presentation for investors. Therefore, it should be classified as an Investor Presentation (IP).
2026-05-26 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is a '自己株券買付状況報告書' (Report on Status of Purchase of Own Shares) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. This document specifically details the company's share buyback activities (repurchase of own shares) for the period of February 2026. According to the provided definitions, reports regarding the company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2026-03-13 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of the contents of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS). H1 39
2025-11-12 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.